Zymeworks, Inc. (ZYME)
26.61
-1.00
(-3.62%)
USD |
NASDAQ |
May 07, 16:00
25.50
-1.11
(-4.17%)
After-Hours: 20:00
Zymeworks Research and Development Expense (Annual) : 137.00M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Royalty Pharma Plc | 452.00M |
| Johnson & Johnson | 14.83B |
| Krystal Biotech, Inc. | 52.32M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Catalyst Pharmaceuticals, Inc. | 12.71M |